BioNTech, founded by Turkish immigrants to Germany, and its US partner Pfizer on Tuesday announced starting of clinical study “to evaluate safety tolerability and immunogenicity of an Omicron-based vaccine candidate.” In a statement, the two companies announced the launching of a clinical study saying that it will be carried out on “healthy adults 18 through...
The highest monthly CAD in the history of the republic
What matters on Tuesday, March 21
What matters on Monday, March 20
Dollar lost its savings instrument edge
Quake-hit cities to get investment support
15% of earthquake victim voters migrated
What matters on Tuesday, March 14
A law specific to Istanbul is a must: Mayor of Istanbul
Share of compensation of employees in the GVA hits a 25-year low
Hunger limit doesn’t fit in wallets; new banknote is needed
Opposition bloc eyes deal to reunite, elevate popular mayors
Central Bank and SFD ink USD 5bn deposit deal
What matters on Monday, March 6
A big slowdown in the rate of interest reduction!
Economy expands by 5.6% in 2022
Mortality statistics rise by tenfold due to COVID-19
What matters on Tuesday, February 28
Central Bank cuts interest rate by 50 basis points
Will earthquake aids open a diplomatic channel?
January 26, 2022January 26, 2022by CommentaryIn Daily News